CTLA4 promoter polymorphisms are associated with canine diabetes mellitus

Tissue Antigens

Volumn 75, Issue 3, 2010, Pages 242-252

  Short, A D ^a   Saleh, N M ^a   Catchpole, B ^b   Kennedy, L J ^a   Barnes, A ^c   Jones, C A ^d   Fretwell, N ^d   Ollier, W E R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d WALTHAM CENTRE FOR PET NUTRITION   (United Kingdom)

Author keywords

Canine diabetes; CTLA4; Single nucleotide polymorphisms

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ARTICLE; AUTOIMMUNE DISEASE; DIABETES MELLITUS; DOG; EXON; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; IMMUNE RESPONSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; AUTOIMMUNE DISEASES; BASE SEQUENCE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DOG DISEASES; DOGS; EXONS; GENETIC ASSOCIATION STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REGULATORY SEQUENCES, NUCLEIC ACID;

CANIS FAMILIARIS;

EID: 76249089064     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2009.01434.x     Document Type: Article

References (29)

1. Davison LJ, Herrtage ME, Catchpole B. Study of 253 dogs in the United Kingdom with diabetes mellitus. Vet Rec 2005 : 156 : 467 471.
2. Guptill L, Glickman L, Glickman N. Time trends and risk factors for diabetes mellitus in dogs: analysis of veterinary medical data base records (1970-1999). Vet J 2003 : 165 : 240 247.
3. Catchpole B, Ristic JM, Fleeman LM, Davison LJ. Canine diabetes mellitus: can old dogs teach us new tricks? Diabetologia 2005 : 48 : 1948 1956.
4. Davison LJ, Weenink SM, Christie MR, Herrtage ME, Catchpole B. Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus. Vet Immunol Immunopathol 2008 : 126 : 83 90.
5. Kennedy LJ, Davison LJ, Barnes A et al. Identification of susceptibility and protective major histocompatibility complex haplotypes in canine diabetes mellitus. Tissue Antigens 2006 : 68 : 467 476.
6. Short AD, Catchpole B, Kennedy LJ et al. Analysis of candidate susceptibility genes in canine diabetes. J Hered 2007 : 98 : 518 525.
7. Short AD, Catchpole B, Kennedy LJ et al. T cell cytokine gene polymorphisms in canine diabetes mellitus. Vet Immunol Immunopathol 2009 128 : 137 146.
8. Ueda H, Howson JM, Esposito L et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003 : 423 : 506 511.
9. Turpeinen H, Laine AP, Hermann R et al. A linkage analysis of the CTLA4 gene region in Finnish patients with type 1 diabetes. Eur J Immunogenet 2003 : 30 : 289 293.
10. Zalloua PA, Abchee A, Shbaklo H et al. Patients with early onset of type 1 diabetes have significantly higher GG genotype at position 49 of the CTLA4 gene. Hum Immunol 2004 : 65 : 719 724.
11. Erfani N, Razmkhah M, Talei AR et al. Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer Genet Cytogenet 2006 : 165 : 114 120.
12. Blomhoff A, Lie BA, Myhre AG et al. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J Clin Endocrinol Metab 2004 : 89 : 3474 3476.
13. Serrano NC, Millan P, Paez MC. Non-HLA associations with autoimmune diseases. Autoimmun Rev 2006 : 5 : 209 214.
14. Wang XB, Zhao X, Giscombe R, Lefvert AK. A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes Immun 2002 : 3 : 233 234.
15. Short AD. The genetics of canine diabetes: a candidate gene study. 2006.
16. Short AD, Kennedy LJ, Barnes A et al. Hardy Weinberg expectations in canine breeds: implications for genetic studies. J Hered 2007 : 98 : 445 451.
17. Short AD, Catchpole B, Kennedy LJ et al. Analysis of candidate susceptibility genes in canine diabetes. J Hered 2007 98 : 518 525.
18. Sham PC, Curtis D. Monte Carlo tests for association between disease and alleles at highly polymorphic loci. 1995 : 59 : 97 105.
19. Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007 : 81 : 559 575.
20. Montgomery TM, Nelson RW, Feldman EC, Robertson K, Polonsky KS. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism. J Vet Intern Med 1996 : 10 : 116 122.
21. Mattheeuws D, Rottiers R, Kaneko JJ, Vermeulen A. Diabetes mellitus in dogs: relationship of obesity to glucose tolerance and insulin response. Am J Vet Res 1984 : 45 : 98 103.
22. Bouqbis L, Izaabel H, Akhayat O et al. Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population. Genes Immun 2003 : 4 : 132 137.
23. Osei-Hyiaman D, Hou L, Zhiyin R et al. Association of a novel point mutation (C159G) of the CTLA4 gene with type 1 diabetes in West Africans but not in Chinese. Diabetes 2001 : 50 : 2169 2171.
24. Hermann R, Laine AP, Veijola R et al. The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity. Diabetologia 2005 : 48 : 1766 1775.
25. Nithiyananthan R, Heward JM, Allahabadia A, Franklyn JA, Gough SC. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid 2002 : 12 : 3 6.
26. Steck AK, Bugawan TL, Valdes AM et al. Association of non-HLA genes with type 1 diabetes autoimmunity. Diabetes 2005 : 54 : 2482 2486.
27. Lee YJ, Lo FS, Shu SG et al. The promoter region of the CTLA4 gene is associated with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2001 : 14 : 383 388.
28. Heward JM, Allahabadia A, Carr-Smith J et al. No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies. Clin Endocrinol (Oxf) 1998 : 49 : 331 334.
29. Wong EY, Lin J, Forget BG, Bodine DM, Gallagher PG. Sequences downstream of the erythroid promoter are required for high level expression of the human alpha-spectrin gene. J Biol Chem 2004 : 279 : 55024 55033.